TACR1 and breast cancer: Interestingly, the NK1R antagonist aprepitant effectively inhibited the metastasis-promoting effects of neural substance P in human breast and mammary cancer-bearing mice (Padmanaban et al., 2024), demonstrating the feasibility of such an approach.